AI: from hype to results

These days, it feels like you can’t move in pharma without bumping into another AI slogan promising to “revolutionise” everything: apparently groundbreaking solutions that could revolutionise the industry and, while they’re at it, solve world peace.

But for senior leaders in commercial and medical affairs, the reality is far more complex. How do you cut through the noise to figure out which innovations actually fix problems and which are just shiny distractions in disguise? How do you scale new tech across sprawling global teams while sidestepping potential landmines (like potential changes in US regulations, or the EU AI Act)?

This webinar gets real. We’re focussing on what actually works, spotlighting tangible results from teams who’ve cracked the code on turning promise into performance. You’ll hear how organisations are driving serious impact—rolling out AI to thousands of users, boosting engagement, and dodging the usual chaos of implementation. Forget empty buzzwords, you’ll see real numbers and real performance shifts. You’ll hear the pitfalls from those who are scaling AI across commercial and medical functions, ensuring that the tools deliver value, not just hype.

With the EU AI Act and US regulatory evolution introducing high-risk classifications that could disrupt critical applications like HCP engagement and decision support, the stakes have never been higher. With potential fines reaching 6% of revenues—or perhaps worse, the erosion of trust with HCPs and patients—getting this right isn’t optional.

This session offers a clear-eyed perspective on how to align compliance with innovation, future-proof your operations, and ensure your AI strategy delivers results that matter. If you’re tired of hype, want to future-proof operations and want practical insights on making AI a success, this session is for you.

See the impact for yourself. Register today.